| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human |
| Host species | Rabbit |
| Applications | IHC-P,WB-Re |
| Brand: | Abnova |
| Reference: | PAB19527 |
| Product name: | CXCL10 polyclonal antibody |
| Product description: | Rabbit polyclonal antibody raised against synthetic peptide of CXCL10. |
| Isotype: | IgG |
| Gene id: | 3627 |
| Gene name: | CXCL10 |
| Gene alias: | C7|IFI10|INP10|IP-10|SCYB10|crg-2|gIP-10|mob-1 |
| Gene description: | chemokine (C-X-C motif) ligand 10 |
| Immunogen: | A synthetic peptide corresponding to amino acids at C-terminus of human CXCL10. |
| Form: | Lyophilized |
| Recommend dilutions: | Western Blot (1 ug/mL) Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) (1 ug/mL) The optimal working dilution should be determined by the end user. |
| Storage buffer: | Lyophilized from 0.9 mg NaCl, 0.2 mg Na2HPO4 (5 mg BSA, 0.05 mg sodium azide, 0.05 mg Thimerosal) |
| Storage instruction: | Store at -20°C on dry atmosphere. After reconstitution with 200 uL of deionized water and concentration will be 500 ug/mL, store at -20°C or lower. Aliquot to avoid repeated freezing and thawing. |
| Note: | This product contains sodium azide and thimerosal: POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Rabbit |
| Antigen species / target species: | Human |
| Specificity: | It identical to the related mouse and rat sequences. |
| Reactivity: | Human |
| Application image: | ![]() |
| Application image note: | Immunohistochemical staining of paraffin-embedded human mammary cancer tissue section with CXCL10 polyclonal antibody (Cat # PAB19527). |
| Applications: | IHC-P,WB-Re |
| Shipping condition: | Dry Ice |
| Publications: | Human anaplastic thyroid carcinoma cells are sensitive to NK cell-mediated lysis via ULBP2/5/6 and chemoattract NK cells.Wennerberg E, Pfefferle A, Ekblad L, Yoshimoto Y, Kremer V, Kaminskyy VO, Juhlin CC, Hoog A, Bodin I, Svjatoha V, Larsson C, Zedenius J, Wennerberg J, Lundqvist A Clin Cancer Res. 2014 Sep 11. pii: clincanres.0291.2014. |